Jianyang Fang

xia men university

H指数:13

被引数:740

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Theranostic Study of PSMA-Targeted Radioligands Modified with Enhancer SNAC

PSMA靶向放射性配体经增强剂SNAC修饰的诊疗学研究

Journal of Medicinal Chemistry

IF6.8

2026-05-130

PRE

Development of Lipid-Engineered PSMA-Targeted Radioligands with Quinoline Scaffold

脂质工程PSMA靶向放射性配体（基于喹啉骨架）的开发

Journal of Medicinal Chemistry

IF6.8

2026-04-220

PRE

Development of a Novel Approach for In Vivo Tumor Hypoxia PET Imaging with Nitroreductase-Specific Responsive Radiotracers

一种利用亚硝基还原酶特异性响应放射性示踪剂进行活体肿瘤缺氧PET成像的新方法开发

Molecular Pharmaceutics

IF4.5

2026-02-180

PRE

Development of radioligands with an albumin-binding moiety of 4-(P-Iodophenyl) butyric acid for theranostic applications

用于诊疗应用的、含有4-(对碘苯基)丁酸白蛋白结合基团的放射性配体的开发

JOURNAL OF CONTROLLED RELEASE

IF11.5

2025-06-010

PRE

FAP-targeted delivery of radioiodinated probes: A progressive albumin-driven strategy for tumor theranostics

放射性碘标记探针的FAPI靶向递送：一种进步的由白蛋白驱动的肿瘤诊疗策略

JOURNAL OF CONTROLLED RELEASE

IF11.5

2025-06-011

PRE

Exploration of Bicyclic Peptide Ligands for Immune-Specific PET Imaging: Targeting Tumor PD-L1 with [18F]AlF-BCY10959

探索用于免疫特异性PET成像的双环肽配体：靶向肿瘤PD-L1的[18F]AlF-BCY10959

MOLECULAR PHARMACEUTICS

IF4.5

2025-05-080

PRE

Modification of Asp-Peptide Adapters: Giving the FAP-Targeted Radioligand a Squirrel Tail

天冬氨酸-肽适配体的修饰：为FAP靶向放射性配体添加松鼠尾

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2025-03-180

PRE

Development of STING probes and visualization of STING in multiple tumor types

STING探针的开发和STING在多种肿瘤类型中的可视化

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2024-09-180

PRE

Development of Preladenant-Based Radiotracers for Imaging A2AR in Tumors

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-07-220

PRE

Rational Design and Pharmacomodulation of 18F-Labeled Biotin/FAPI-Conjugated Heterodimers

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-05-103

PRE

Rational Design and Comparison of Novel 99mTc-Labeled FAPI Dimers for Visualization of Multiple Tumor Types

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-05-082

PRE

Fibroblast Activation Protein Inhibitor Tracers and Their Preclinical, Translational, and Clinical Status in China

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2024-05-065

PRE

Development of small-molecular-based radiotracers for PET imaging of PD-L1 expression and guiding the PD-L1 therapeutics

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2024-01-226

PRE

Design, Preclinical Evaluation, and Clinical Translation of 68Ga-FAPI-LM3, a Heterobivalent Molecule for PET Imaging of Nasopharyngeal Carcinoma

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2024-01-049

OAAI

Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2023-06-1531

OAAI

Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2023-04-2516

PRE

A novel 18F-labeled agonist for PET imaging of stimulator of interferon gene expression in tumor-bearing mice

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2022-09-0611

PRE

Development of a novel radiofluorinated riboflavin probe for riboflavin receptor-targeting PET imaging

PHARMACOLOGICAL RESEARCH

IF10.5

2022-09-015

PRE

68Ga-Labeled Maleimide for Blood Pool and Lymph PET Imaging through Covalent Bonding to Serum Albumin In Vivo

ACS OMEGA

IF4.3

2022-08-054

OAAI

Preclinical and first-in-human evaluation of 18F-labeled D-peptide antagonist for PD-L1 status imaging with PET

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2022-07-1423

PRE

Jianyang Fang

个人简介

教育背景

工作经历

荣誉奖项

研究方向